The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma

Evangelos Terpos; Meletios A Dimopoulos; Orhan Sezer

doi:10.1038/sj.leu.2404843

Related publications

Article2009

Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Meletios A Dimopoulos

Article2015

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, Sossana Delimpasis, Argiris Symeonidis, Panagiotis Repousis, Marie‐Christine Kyrtsonis, Chrysa Vadikolia, Eurydiki Michalis, Genovefa Polychronidou, Michalis Michael, Sofia Papadaki, Μαρία Παπαθανασίου, Kyriaki Kokoviadou, Anna Kioumi, Efthymia Vlachaki, Christina Hadjiaggelidou, Alexandra Kouraklis, Ioannis Patsias, Maria Gavriatopoulou, Maria Kotsopoulou, Evgenia Verrou, Vasiliki Gastari, Dimitrios Christoulas, Evlambia Giannopoulou, Anastasia Pouli, Pavlina Konstantinidou, Αchilles Anagnostopoulos, Meletios A Dimopoulos

Article2012

The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma

Discussion(0)

Related publications

Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment

Novel anti-myeloma agents and angiogenesis

Multiple Myeloma in the Era of Novel Agents